Cerity Partners LLC lifted its stake in shares of Owens & Minor, Inc. (NYSE:OMI – Free Report) by 3.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 101,390 shares of the company’s stock after acquiring an additional 3,383 shares during the period. Cerity Partners LLC’s holdings in Owens & Minor were worth $1,954,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of OMI. Deerfield Management Company L.P. Series C lifted its position in shares of Owens & Minor by 35.6% during the 3rd quarter. Deerfield Management Company L.P. Series C now owns 6,435,000 shares of the company’s stock valued at $103,990,000 after acquiring an additional 1,690,000 shares during the period. FMR LLC increased its stake in Owens & Minor by 10.6% during the 3rd quarter. FMR LLC now owns 11,479,209 shares of the company’s stock valued at $185,504,000 after purchasing an additional 1,103,275 shares in the last quarter. Deutsche Bank AG increased its stake in Owens & Minor by 278.0% during the 3rd quarter. Deutsche Bank AG now owns 694,248 shares of the company’s stock valued at $11,219,000 after purchasing an additional 510,596 shares in the last quarter. Nuveen Asset Management LLC increased its stake in Owens & Minor by 61.8% during the 2nd quarter. Nuveen Asset Management LLC now owns 1,288,925 shares of the company’s stock valued at $24,541,000 after purchasing an additional 492,348 shares in the last quarter. Finally, Alyeska Investment Group L.P. bought a new stake in Owens & Minor during the 1st quarter valued at $20,483,000. Institutional investors and hedge funds own 98.04% of the company’s stock.
Owens & Minor Stock Performance
NYSE OMI opened at $24.79 on Friday. Owens & Minor, Inc. has a 1 year low of $13.34 and a 1 year high of $28.35. The company has a debt-to-equity ratio of 2.05, a current ratio of 1.11 and a quick ratio of 0.52. The firm has a market cap of $1.90 billion, a price-to-earnings ratio of -45.90, a PEG ratio of 0.76 and a beta of 0.43. The company has a fifty day moving average price of $24.90 and a 200-day moving average price of $20.80.
Analysts Set New Price Targets
OMI has been the subject of a number of recent research reports. Barclays boosted their price target on shares of Owens & Minor from $21.00 to $23.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 21st. Robert W. Baird boosted their price target on shares of Owens & Minor from $24.00 to $28.00 and gave the company a “neutral” rating in a research note on Wednesday, April 10th. TheStreet upgraded shares of Owens & Minor from a “d+” rating to a “c-” rating in a research note on Monday, March 4th. StockNews.com upgraded shares of Owens & Minor from a “hold” rating to a “buy” rating in a research note on Wednesday, February 21st. Finally, Leerink Partnrs reiterated a “market perform” rating on shares of Owens & Minor in a research note on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $23.29.
Read Our Latest Stock Report on OMI
Insider Buying and Selling
In related news, SVP Michael Wayne Lowry sold 10,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the transaction, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 3.59% of the stock is owned by insiders.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Read More
- Five stocks we like better than Owens & Minor
- What is the Dow Jones Industrial Average (DJIA)?
- Comprehensive Analysis of PayPal Stock
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Election Stocks: How Elections Affect the Stock Market
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.